Critical Limb Ischemia (CLI) is the most severe clinical manifestation of Peripheral Artery Disease (PAD). CLI is caused by severe blockages in the arteries of the lower limbs, significantly reducing blood flow, eventually completely blocking the artery and forming Chronic Total Occlusion (CTO).Patients with CLTI often experience profound chronic pain and develop wounds or infections that lead to severe amputations, closely associated with increased mortality and reduced quality of life.
And this patient population is very large, with 25 to 30 million people worldwide, and more than 3 million people in the United States alone suffering from CLI.The prognosis for CLI patients is very poor, with 25% of patients dying within one year and 30% requiring subsequent amputation (the mortality rate reaches 70% after five years).
To alleviate the symptoms of CLTI, patients are primarily treated with angioplasty or bypass surgery. Compared to bypass surgery,AngioplastyWith less invasiveness, it has gradually become the chosen method of vascular reconstruction for patients with severe peripheral artery disease and CLI. Successful revascularization greatly reduces the need for amputation. However, to break through something as hard as a rock,Fibrous CalcificationThe lesion area is extremely challenging, especially for chronic total occlusion (CTO) lesions (with lengths sometimes exceeding 20 cm). This leads to...AngioplastyThe high failure rate is mainly due to the inability of traditional guidewires to penetrate hard structures.Fibrous CalcificationLesion Area。To this end, many in ChinaInnovative companies inside and outside China have started to develop technologies to overcome hard fibrous calcified lesions. For example, Johnson & Johnson has developedForward-looking shockwave catheter Javelin, the shockwave guidewire SoundBite developed by Soundbite Medical Solutions, a company invested in by a Chinese firm, and the intravascular ultrasound guidewire FastWire developed by Versono Medical, among others.As overseas technologies continue to yield positive results in clinical settings, China is also beginning to adopt innovative foreign technologies. One of the companiesThe intravascular ultrasound guidewire has successfully completed the functional prototype and is now seeking partners. Project Status
Prototype Status:Functional Prototype
Verification Status:Functional verification has been completed, and the evaluation by senior professionals in the industry has shown satisfactory results.
Intellectual Property:Holding one invention patent
Safer energy output; higher work efficiency; precise control of ultrasonic energy; less damage to the inner wall of blood vessels.
Product Application Scope
Chronic Total Occlusion of Coronary Artery and Chronic Total Occlusion of Peripheral Artery
Project Cooperation
Now seeking manufacturer cooperation, cooperation methods:Technical Cooperation
a. If your company hopes to enter the market through innovative productsCardiologyDepartment (Vascular Intervention)Track
b. If your company has deep roots in surgery (Vascular Intervention) track, hoping to enrich the product line through innovative products, enhance the synergy of products, and increase sales.
Please contact us for more details.
Contact Number:Manager Xia 19054103911(WeChat same number)
